OncoTherapy Science, Inc. (4564.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.89B |
| Enterprise Value | 4.8B |
| P/E Ratio | -8.9 |
| PEG Ratio | -0.35 |
| Price/Sales Ratio | 10.76 |
| Price/Book Ratio | 3.57 |
| Enterprise/Revenue | 7.77 |
| Enterprise/EBITDA | -6.69 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.14 |
| Operating Margin | -1.06 |
AD
Management Effectiveness
| Return On Assets | -0.34 |
| Return On Equity | -0.43 |
Income Statement
| Revenue | 808.53M |
| Revenue/Share | 1.95 |
| Gross Profit | 13.96M |
| EBITDA | -810.38M |
| Net Income | -910.64M |
| Diluted EPS | -2.77 |
Balance Sheet
| Total Cash | 2.33B |
| Total Cash/Share | 5.83 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 11.81 |
| Book Value Per Share | 5.89 |
Price History
| 52-Week Change | -25 |
| 52-Week High | 34 |
| 52-Week Low | 18 |
| Moving Average 50 Days | 19.76 |
| Moving Average 200 Days | 21.33 |
Statistics
| Average Volume | 179.82M |
| Shares Outstanding | 398.64M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 500:1 |
| Last Split Date | September 26, 2013 |
AD
